GW Pharmaceuticals to begin trials again

[Oz]

GW Pharmaceuticals, the drugs from cannabis company that has consistently failed to bring its painkilling medicine to market, dived 29 per cent as it said that European Union regulators were making it begin trials again.

 

The shares fell 27p to 65p, a two-year low. GW said that it would withdraw its application for EU approval for Sativex, the spray-under-the-tongue cannabis extract, so that it could conduct further trials.

 

Regulators ruled that there was not enough evidence in its trials that Sativex had any benefit over a placebo and that they must be redone. GW aims to reapply within 12 months.

Author: Robert Lindsay

Date: 21/07/07

Source: Times online

Copyright: 2007 Times Newspapers Ltd.

[WantDaChronic]

its about bloody time someone stood up to the pharmacutical companies and told them that even though their self funded studies say marijuana is about as useful as a sugar pill, that we dont believe them and they have to go back and prove it all over again

[Guest niall]

BUY!

[Stoney]

if i had some cash around i would definatly buy some

 

cheerz :Dj: